Now a company is fielding complaints that its drug works too hard
But even with hundreds of thousands of new prescriptions every year, the widespread incidence of both diabetes and obesity means there is a lot more room to run
Overall, we identified 280 pre-clinical and mechanistic studies (Fig
actual schedules vary by trial arm and protocol): Starting dose: 2 mg once weekly Escalation: doses increased incrementally (e.g., to 4 mg, 8 mg, and up to 12 mg) at intervals of approximately four weeks Maintenance dose: up to 12 mg once weekly in some trial arms These figures are provided for educational context only and must not be used to guide self-dosing
Any weight loss tends to be modest and usually comes with diet changes
Structurally, Retatrutide is a 39-residue peptide made by solid-phase synthesis and incorporates three non-coded amino acid modifications: 2-aminoisobutyric acid (Aib) at positions 2 and 20 for DPP-4 resistance, plus -methyl-leucine (MeL) at position 13 to optimize GIP receptor activity
.jpg)
